Glover v. Bausch & Lomb, Inc.
Court of Appeals for the Second Circuit
1Opinion of the Court
20-1156-cv Glover v. Bausch & Lomb, Inc. UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT August Term, 2020 Argued: March 23, 2021 Fully Submitted Post-Certification: July 22, 2022 Decided: August 8, 2022 Docket No. 20-1156-cv MARJORIE GLOVER, CHARLES GLOVER, Plaintiffs-Appellants, — v. — BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH COMPANIES INC. (F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL, INC.), BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC), BAUSCH HEALTH AMERICAS, INC. (F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL), DOES 1 through 50, inclusive,…
2Cases cited3 opinions
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- United States v. DesimoneCourt of Appeals for the Second Circuit · 1998
- Glover v. Bausch & Lomb, Inc.Court of Appeals for the Second Circuit · 2021
3Cited by4 opinions
- Corrigan v. Covidien LPDistrict Court, D. Massachusetts · 2024
- Gallego v. Tandem Diabetes Care, Inc.District Court, E.D. New York · 2025
- Polson v. AstraZeneca LPDistrict Court, D. Connecticut · 2023
- Tillet v. CooperSurgical, Inc.District Court, W.D. New York · 2023